Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
Xingxin Zhang,1 Chenjian Gu,2 Qian Wei,1 Yirong Cao,1 Weimin She,1 Hong Shi,1 Youhua Xie,2 Jinsheng Guo1 1Department of Gastroenterology and Hepatology; Department of Internal Medicine, Shanghai Medical College, Zhongshan Hospital, Fudan University, Shanghai, 200032, People’s Republic of China; 2Key...
Main Authors: | Zhang X, Gu C, Wei Q, Cao Y, She W, Shi H, Xie Y, Guo J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-04-01
|
Series: | Journal of Hepatocellular Carcinoma |
Subjects: | |
Online Access: | https://www.dovepress.com/pre-s1-mutations-as-indicated-by-serum-pre-s1-antigen-negative-is-asso-peer-reviewed-fulltext-article-JHC |
Similar Items
-
Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)
by: Satinder P. Kaur, et al.
Published: (2022-02-01) -
Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma
by: Yueh-Te Lin, et al.
Published: (2021-05-01) -
Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma
by: Chiao-Fang Teng, et al.
Published: (2020-08-01) -
PreHevbrio: the first approved 3-antigen hepatitis B vaccine
by: Timo Vesikari, et al.
Published: (2023-12-01) -
Approaches for Detection of Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins and Their Application in Prediction of Higher Risk of Hepatocellular Carcinoma Development and Recurrence
by: Yueh-Te Lin, et al.
Published: (2022-02-01)